Header Logo

PATRICK CHAFTARI

TitleAssistant Professor
InstitutionMD Anderson
DepartmentEmergency Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dagher H, Chaftari AM, Hachem R, Jiang Y, Philip A, Mulanovich P, Haddad A, Lamie P, Wilson Dib R, John TM, Dailey Garnes NJM, Ali S, Chaftari P, Raad II. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers (Basel). 2024 Oct 11; 16(20). PMID: 39456544; PMCID: PMC11506002.
      Citations:    
    2. Chaftari AM, Dagher H, Hachem R, Jiang Y, Lamie P, Wilson Dib R, John T, Haddad A, Philip A, Alii S, Mulanovich P, Yuan Y, Chaftari P, Raad I. A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother. 2024 Oct 01; 79(10):2543-2553. PMID: 39092963.
      Citations: 1     Fields:    Translation:HumansCells
    3. Lipe DN, Qdaisat A, Krishnamani PP, Nguyen TD, Chaftari P, El Messiri N, Srinivasan A, Galvis-Carvajal E, Reyes-Gibby CC, Wattana MK. Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review. Diagnostics (Basel). 2024 Aug 16; 14(16). PMID: 39202282; PMCID: PMC11353298.
      Citations:    
    4. Zoghbi M, Moussa MJ, Dagher J, Haroun E, Qdaisat A, Singer ED, Karam YE, Yeung SJ, Chaftari P. Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management. Cancers (Basel). 2024 Jul 19; 16(14). PMID: 39061222; PMCID: PMC11274762.
      Citations:    
    5. Haddad AJ, Hachem RY, Moussa M, Jiang Y, Dagher HR, Chaftari P, Chaftari AM, Raad II. Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients. Cancers (Basel). 2024 Mar 05; 16(5). PMID: 38473412; PMCID: PMC10931258.
      Citations:    
    6. Singer ED, Faiz SA, Qdaisat A, Abdeldaem K, Dagher J, Chaftari P, Yeung SJ. Hemoptysis in Cancer Patients. Cancers (Basel). 2023 Sep 28; 15(19). PMID: 37835458; PMCID: PMC10571539.
      Citations:    
    7. Lipe DN, Qdaisat A, Chaftari P, Wattana MK, Krishnamani PP, Reyes-Gibby C, Yeung SJ. Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy. Front Oncol. 2023; 13:1122329. PMID: 37007139; PMCID: PMC10064130.
      Citations:    
    8. Dagher H, Chaftari AM, Subbiah IM, Malek AE, Jiang Y, Lamie P, Granwehr B, John T, Yepez E, Borjan J, Reyes-Gibby C, Flores M, Khawaja F, Pande M, Ali N, Rojo R, Karp DD, Chaftari P, Hachem R, Raad II. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife. 2023 02 07; 12. PMID: 36748905; PMCID: PMC9977271.
      Citations: 4     Fields:    Translation:HumansCells
    9. Jiang Y, Gorak E, Khawaja F, Granwehr B, John T, Chaftari P, Malek AE, Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Subbiah V, Siddiqui B, Bayle A, Somer R, Fern?ndez Cruz A, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Garc?a AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Kontoyiannis DP, Chaftari AM. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12. PMID: 36715684; PMCID: PMC9981148.
      Citations:    Fields:    Translation:HumansCells
    10. Krishnamani PP, Qdaisat A, Wattana MK, Lipe DN, Sandoval M, Elsayem A, Cruz Carreras MT, Yeung SJ, Chaftari PS. Characteristics and Outcomes of Patients with Cancer Pain Placed in an Emergency Department Observation Unit. Cancers (Basel). 2022 Nov 29; 14(23). PMID: 36497353; PMCID: PMC9738053.
      Citations:    
    11. Elsayem AF, Warneke CL, Reyes-Gibby CC, Buffardi LJ, Sadaf H, Chaftari PS, Brock PA, Page VD, Viets-Upchurch J, Lipe D, Alagappan K. "Triple Threat" Conditions Predict Mortality Among Patients With Advanced Cancer Who Present to the Emergency Department. J Emerg Med. 2022 09; 63(3):355-362. PMID: 36220672.
      Citations:    Fields:    Translation:Humans
    12. Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Garc?a-Garc?a ?, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Kontoyiannis DP, Malek AE, Chaftari AM. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26. PMID: 36097568; PMCID: PMC9465833.
      Citations:    
    13. Lipe DN, Qdaisat A, Rajha E, Al-Breiki A, Cruz Carreras MT, Chaftari P, Yeung SJ, Rice TW. Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis. Res Pract Thromb Haemost. 2022 Aug; 6(6):e12761. PMID: 36000091; PMCID: PMC9391569.
      Citations:    
    14. Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict. 2022 05; 31(3):236-241. PMID: 35347796; PMCID: PMC9117427.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    15. Krishnamani PP, Sandoval M, Chaftari P, Lipe DN, Qdaisat A, Elsayem A, Wattana MK. The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain. Curr Oncol Rep. 2022 05; 24(5):595-602. PMID: 35192121.
      Citations:    Fields:    Translation:Humans
    16. Lipe DN, Chaftari P, Reyes-Gibby C, Palaskas NL. The evolving landscape of chimeric antigen receptor T-cell therapy associated cardiotoxicity. Am J Emerg Med. 2022 07; 57:220-221. PMID: 35246349.
      Citations:    Fields:    Translation:Humans
    17. Chaftari AM, Hachem R, Malek AE, Mulanovich VE, Szvalb AD, Jiang Y, Yuan Y, Ali S, Deeba R, Chaftari P, Raad I. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac079. PMID: 35663286; PMCID: PMC9154317.
      Citations:    
    18. Lipe DN, Bourenane SS, Wattana MK, Gaeta S, Chaftari P, Cruz Carreras MT, Manzano JG, Reyes-Gibby C. A modified emergency severity index level is associated with outcomes in cancer patients with COVID-19. Am J Emerg Med. 2022 Apr; 54:111-116. PMID: 35152119; PMCID: PMC8817422.
      Citations:    Fields:    Translation:HumansCells
    19. Chaftari P, Lipe DN, Wattana MK, Qdaisat A, Krishnamani PP, Thomas J, Elsayem AF, Sandoval M. Outcomes of Patients Placed in an Emergency Department Observation Unit of a Comprehensive Cancer Center. JCO Oncol Pract. 2022 04; 18(4):e574-e585. PMID: 34905410; PMCID: PMC9014449.
      Citations:    Fields:    Translation:Humans
    20. Araji G, Maamari J, Ahmad FA, Zareef R, Chaftari P, Yeung SJ. The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review. J Immunother Precis Oncol. 2022 Feb; 5(1):13-25. PMID: 35663831; PMCID: PMC9138420.
      Citations:    
    21. Malek AE, Khalil M, Hachem R, Chaftari AM, Fares J, Jiang Y, Kontoyiannis DP, Fossella F, Chaftari P, Mulanovich VE, Viola GM, Raad II. Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704. PMID: 32564081.
      Citations: 2     Fields:    Translation:Humans
    22. Chaftari P, Chaftari AM, Hachem R, Yeung SJ, Dagher H, Jiang Y, Malek AE, Dailey Garnes N, Mulanovich VE, Raad I. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med. 2021 12; 10(23):8475-8482. PMID: 34725958; PMCID: PMC8633259.
      Citations: 1     Fields:    Translation:Humans
    23. Chaftari P, Qdaisat A, Chaftari AM, Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G, Yeung SJ. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel). 2021 Aug 13; 13(16). PMID: 34439240; PMCID: PMC8393196.
      Citations: 1     
    24. Lipe DN, Rajha E, Wechsler AH, Gaeta S, Palaskas NL, Alhajji Z, Viets-Upchurch J, Chaftari P. Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy. Am J Emerg Med. 2021 12; 50:51-58. PMID: 34274878.
      Citations: 1     Fields:    Translation:Humans
    25. Lipe DN, Palaskas NL, Chaftari P. Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis. J Med Toxicol. 2022 01; 18(1):63-64. PMID: 34227031; PMCID: PMC8758869.
      Citations:    Fields:    Translation:Humans
    26. Yeung SJ, Qdaisat A, Chaftari P, Lipe D, Merlin J, Rajha E, Wechsler A, Sandoval M, Viets J, Al-Breiki A, Shah M, Pandey R, Kamal M, Khattab O, Toale K, Wattana M, Elsayem A, Gaeta S, Brock P, Reyes-Gibby C, Alagappan K. Diagnosis and management of immune-related adverse effects of immune checkpoint therapy in the emergency department. J Am Coll Emerg Physicians Open. 2020 Dec; 1(6):1637-1659. PMID: 33392573; PMCID: PMC7771833.
      Citations: 4     
    27. Qdaisat A, Wu W, Lin JZ, Al Soud R, Yang Z, Hu Z, Gao S, Wu CC, Liu X, Silvestre J, Hita AG, Viets-Upchurch J, Al Adwan S, Al Haj Qasem N, Cruz Carreras MT, Jacobson KL, Chaftari PS, Abdel-Razeq H, Reyes-Gibby CC, Jim Yeung SC. Clinical and Cancer-Related Predictors for Venous Thromboembolism in Cancer Patients Presenting to the Emergency Department. J Emerg Med. 2020 Jun; 58(6):932-941. PMID: 32376060.
      Citations: 2     Fields:    Translation:Humans
    28. Rajha E, Chaftari P, Kamal M, Maamari J, Chaftari C, Yeung SJ. Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy. Gastroenterol Rep (Oxf). 2020 Feb; 8(1):25-30. PMID: 32104583; PMCID: PMC7034236.
      Citations: 8     
    29. El Majzoub I, Qdaisat A, Chaftari PS, Yeung SJ, Sawaya RD, Jizzini M, Carreras MTC, Abunafeesa H, Elsayem AF. Association of emergency department admission and early inpatient palliative care consultation with hospital mortality in a comprehensive cancer center. Support Care Cancer. 2019 Jul; 27(7):2649-2655. PMID: 30474736.
      Citations: 7     Fields:    Translation:Humans
    30. Maamari J, Yeung SJ, Chaftari PS. Diabetic ketoacidosis induced by a single dose of pembrolizumab. Am J Emerg Med. 2019 02; 37(2):376.e1-376.e2. PMID: 30361152.
      Citations: 14     Fields:    Translation:Humans
    31. El Haddad H, Chaftari AM, Hachem R, Chaftari P, Raad II. Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer. Clin Infect Dis. 2018 08 31; 67(6):971-977. PMID: 29668936.
      Citations: 8     Fields:    Translation:Humans
    32. Reyes-Gibby CC, Wang J, Yeung SJ, Chaftari P, Yu RK, Hanna EY, Shete S. Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep. 2018 06 08; 8(1):8789. PMID: 29884837; PMCID: PMC5993794.
      Citations: 5     Fields:    Translation:Humans
    33. El Majzoub I, Qdaisat A, Thein KZ, Win MA, Han MM, Jacobson K, Chaftari PS, Prejean M, Reyes-Gibby C, Yeung SJ. Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center. Ann Emerg Med. 2019 01; 73(1):79-87. PMID: 29880440.
      Citations: 25     Fields:    Translation:Humans
    34. El Haddad H, Chaftari AM, Hachem R, Michael M, Jiang Y, Yousif A, Raad S, Jordan M, Chaftari P, Raad I. Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 Apr 19; 8(1):6258. PMID: 29674672; PMCID: PMC5908871.
      Citations:    Fields:    
    35. Karam-Hage M, Kypriotakis G, Robinson JD, Green CE, Mann G, Rabius V, Wippold R, Blalock JA, Mouhayar E, Tayar J, Chaftari P, Cinciripini PM. Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis. J Clin Psychopharmacol. 2018 Feb; 38(1):34-41. PMID: 29232312; PMCID: PMC5997410.
      Citations:    Fields:    Translation:Humans
    36. Haddad HE, Chaftari AM, Hachem R, Michael M, Jiang Y, Yousif A, Raad S, Jordan M, Chaftari P, Raad I. Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 01 18; 8(1):1099. PMID: 29348438; PMCID: PMC5773566.
      Citations: 4     Fields:    
    37. Chaftari AM, Hachem R, Raad S, Jiang Y, Natividad E, Chaftari P, Raad I. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infect Control Hosp Epidemiol. 2018 02; 39(2):222-225. PMID: 29331162.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    38. Cruz-Carreras MT, Chaftari P, Viets-Upchurch J. Advance care planning: challenges at the emergency department of a cancer care center. Support Care Cancer. 2018 02; 26(2):585-588. PMID: 28918550; PMCID: PMC5752753.
      Citations: 4     Fields:    Translation:Humans
    39. Cruz-Carreras MT, Chaftari P, Shamsnia A, Guha-Thakurta N, Gonzalez C. Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department. Clin Case Rep. 2017 10; 5(10):1644-1648. PMID: 29026563; PMCID: PMC5628205.
      Citations: 6     
    40. Chaftari P, Chaftari AM, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Ellickalputhenpura B, Jiang Y, Tarrand J, Raad I. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control. 2017 Mar 01; 45(3):e34-e39. PMID: 28254252.
      Citations: 2     Fields:    Translation:Humans
    41. Elsayem AF, Merriman KW, Gonzalez CE, Yeung SC, Chaftari PS, Reyes-Gibby C, Todd KH. Presenting Symptoms in the Emergency Department as Predictors of Intensive Care Unit Admissions and Hospital Mortality in a Comprehensive Cancer Center. J Oncol Pract. 2016 05; 12(5):e554-63. PMID: 27072570.
      Citations: 9     Fields:    Translation:Humans
    42. Wu W, Liu X, Chaftari P, Cruz Carreras MT, Gonzalez C, Viets-Upchurch J, Merriman K, Tu SM, Dalal S, Yeung SC. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review. PLoS One. 2015; 10(3):e0122047. PMID: 25822612; PMCID: PMC4379069.
      Citations: 13     Fields:    Translation:Humans
    43. Bazerbashi H, Merriman KW, Toale KM, Chaftari P, Cruz Carreras MT, Henderson JD, Yeung SC, Rice TW. Low tissue oxygen saturation at emergency center triage is predictive of intensive care unit admission. J Crit Care. 2014 Oct; 29(5):775-9. PMID: 24973103.
      Citations: 5     Fields:    Translation:Humans
    44. Huang YW, Hamilton A, Arnuk OJ, Chaftari P, Chemaly R. Current drug therapy for multiple myeloma. Drugs. 1999 Apr; 57(4):485-506. PMID: 10235689.
      Citations: 2     Fields:    Translation:Humans
    45. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer. PLoS One. 10.
    46. Presenting symptoms in the emergency department as predictors of intensive care unit admissions and hospital mortality in a comprehensive cancer center. Journal of Oncology Practice. 12:e554-e563.
    CHAFTARI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (141)
    Explore
    _
    Co-Authors (46)
    Explore
    _
    Similar People (59)
    Explore
    _
    Same Department Expand Description
    Explore
    _